Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
1,401.00 GBX | -0.76% | -1.16% | -2.55% |
Nov. 28 | Pfizer disappointed in RSV shot's market share, CFO says | RE |
Nov. 28 | Novartis Touts R&D Pipeline Progress, Upgraded Midterm Targets as Pure-play Medicines Company | MT |
Evolution of the average Target Price on GSK plc
Price target over the last 5 years
History : Analyst Recommendations
af7285a42.6BurjsfgYhQEJSgDBLMgQbKC9GF7rTRUURk_inojtlw.jl3J4fHQBndlQV95bNFXJ-TWgDQ5_VoaBn5l5B1I1CStaPO6ktYlcDB_cQ~dcebbe62660f5d8ef5000a74a248f89e
More recommendations
Analysts' Consensus
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
14.12GBP
Average target price
17.25GBP
Spread / Average Target
+22.16%
High Price Target
25.30GBP
Spread / Highest target
+79.20%
Low Price Target
11.90GBP
Spread / Lowest Target
-15.71%
Consensus detail
Consensus revision (last 18 months)
Analysts covering GSK plc
DEUTSCHE BANK RESEARCH | Emmanuel Papadakis |
Jefferies & Co. | |
JEFFERIES | Peter Welford |
Berenberg Bank | |
BERENBERG | Kerry Holford |
JPMorgan | |
alphavalue | Abhishek Raval |
UBS | Colin White |
Morgan Stanley | |
BARCLAYS | Emily Field |
CREDIT SUISSE | Dominic Lunn |
HSBC | |
Deutsche Bank Securities | |
GOLDMAN SACHS | Keyur Parekh |
Bank of America Securities/Merrill Lynch | |
Citigroup | |
Stifel Nicolaus | |
ODDO BHF | |
Societe Generale | |
DZ Bank | |
Liberum Capital | |
J.P. Morgan Chase | |
DEUTSCHE BANK | Emmanuel Papadakis |
KEPLER CHEUVREUX | David Evans |
BAADER BANK | |
SVB Leerink | |
LBBW | |
BANK OF AMERICA (BOFA) | Graham Parry |
Trading Rating :
Investor Rating :
ESG Refinitiv :
B
EPS Revisions
- Stock
- Equities
- Stock GSK plc - London Stock Exchange
- Consensus GSK plc